Search the collection

28 results for Ariyasu,+Mari

Sort by:

Sort by

Limit results to:

20 per page

28 results for Ariyasu,+Mari

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa
Author / Creator:Edgeworth, Jonathan D. ; Merante, Domenico ; Patel, Sanjay ; Young, Christopher ; Jones, Paul ; Vithlani, Seema ; Wyncoll, Duncan ; Roberts, Peter ; Jones, Andrew ; Den Nagata, Tsutae ; Ariyasu, Mari ; Livermore, David M ; Beale, Richard
Publisher:US: Oxford University Press
Journal title:Clinical infectious diseases, 2019-05, Vol.68 (11), p.1932-1934
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings
Author / Creator:Iwata, Satoshi ; Sonoyama, Takuhiro ; Kamitani, Akari ; Shibata, Risa ; Homma, Tomoyuki ; Omoto, Shinya ; Igarashi, Kenji ; Ariyasu, Mari
Publisher:Netherlands: Elsevier Ltd
Journal title:Vaccine, 2022-06, Vol.40 (27), p.3721-3726
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults
Author / Creator:Iwata, Satoshi ; Pollard, Andrew J. ; Tada, Yukio ; Omoto, Shinya ; Shibata, Risa Y. ; Igarashi, Kenji ; Hasegawa, Takahiro ; Ariyasu, Mari ; Sonoyama, Takuhiro
Publisher:London: Nature Publishing Group UK
Journal title:Scientific reports, 2024-04, Vol.14 (1), p.9830-11, Article 9830
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens – The International, Multicenter, Randomized, Open-Label, Phase 3...
Author / Creator:Bassetti, Matteo ; Ariyasu, Mari ; Binkowitz, Bruce ; Nagata, Tsutae Den ; Echols, Roger M. ; Matsunaga, Yuko ; Toyoizumi, Kiichiro ; Doi, Yohei
Publisher:New Zealand: Dove Medical Press Limited
Journal title:Infection and drug resistance, 2019-01, Vol.12, p.3607-3623
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, mult...
Author / Creator:Bassetti, Matteo ; Echols, Roger ; Matsunaga, Yuko ; Ariyasu, Mari ; Doi, Yohei ; Ferrer, Ricard ; Lodise, Thomas P ; Naas, Thierry ; Niki, Yoshihito ; Paterson, David L ; Portsmouth, Simon ; Torre-Cisneros, Julian ; Toyoizumi, Kiichiro ; Wunderink, Richard G ; Nagata, Tsutae D
Publisher:United States: Elsevier Ltd
Journal title:The Lancet infectious diseases, 2021-02, Vol.21 (2), p.226-240
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
Author / Creator:Portsmouth, Simon ; van Veenhuyzen, David ; Echols, Roger ; Machida, Mitsuaki ; Ferreira, Juan Camilo Arjona ; Ariyasu, Mari ; Tenke, Peter ; Nagata, Tsutae Den
Publisher:United States: Elsevier Ltd
Journal title:The Lancet infectious diseases, 2018-12, Vol.18 (12), p.1319-1328
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
Author / Creator:Wunderink, Richard G ; Matsunaga, Yuko ; Ariyasu, Mari ; Clevenbergh, Philippe ; Echols, Roger ; Kaye, Keith S ; Kollef, Marin ; Menon, Anju ; Pogue, Jason M ; Shorr, Andrew F ; Timsit, Jean-Francois ; Zeitlinger, Markus ; Nagata, Tsutae D
Publisher:United States: Elsevier Ltd
Journal title:The Lancet infectious diseases, 2021-02, Vol.21 (2), p.213-225
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesPeer ReviewedFull Text
Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study
Author / Creator:Shinkai, Masaharu ; Sonoyama, Takuhiro ; Kamitani, Akari ; Shibata, Risa Yokokawa ; Seki, Naomi M ; Omoto, Shinya ; Shinoda, Masahiro ; Sato, Takashi ; Ishii, Naoki ; Igarashi, Kenji ; Ariyasu, Mari
Publisher:Netherlands: Elsevier Ltd
Journal title:Vaccine, 2022-07, Vol.40 (32), p.4328-4333
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesPeer ReviewedFull Text
A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial
Author / Creator:Dinh Thiem, Vu ; Van Anh, Pham Thi ; Van Men, Chu ; Hung, Do Thai ; Pollard, Andrew J ; Kamitani, Akari ; Tada, Yukio ; Fukuyama, Hidenori ; Iwasaki, Yuka ; Ariyasu, Mari ; Sonoyama, Takuhiro
Publisher:Netherlands: Elsevier Ltd
Journal title:Vaccine, 2024-06, Vol.42 (17), p.3699-3709
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 10
ArticlesPeer ReviewedFull Text
Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Author / Creator:Talbot, George H ; Das, Anita ; Cush, Stephanie ; Dane, Aaron ; Wible, Michele ; Echols, Roger ; Torres, Antoni ; Cammarata, Sue ; Rex, John H ; Powers, John H ; Fleming, Thomas ; Loutit, Jeffrey ; Hoffmann, Steve
Publisher:United States: Oxford University Press
Journal title:The Journal of infectious diseases, 2019-05, Vol.219 (10), p.1536-1544
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 11
ArticlesPeer ReviewedFull Text
Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults
Author / Creator:Sonoyama, Takuhiro ; Iwata, Satoshi ; Shinkai, Masaharu ; Iwata-Yoshikawa, Naoko ; Shiwa-Sudo, Nozomi ; Hemmi, Takuya ; Ainai, Akira ; Nagata, Noriyo ; Matsunaga, Nobuaki ; Tada, Yukio ; Homma, Tomoyuki ; Omoto, Shinya ; Yokokawa Shibata, Risa ; Igarashi, Kenji ; Suzuki, Tadaki ; Hasegawa, Hideki ; Ariyasu, Mari
Publisher:Netherlands: Elsevier Ltd
Journal title:Vaccine, 2023-03, Vol.41 (11), p.1834-1847
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 12
ArticlesPeer ReviewedFull Text
Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Heal...
Author / Creator:Talbot, George H. ; Powers, John H. ; Hoffmann, Steven C.
Publisher:United States: Oxford University Press
Journal title:Clinical infectious diseases, 2016-03, Vol.62 (5), p.603-607
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 13
ArticlesPeer ReviewedFull Text
1311. Intrapulmonary Pharmacokinetics of Cefiderocol in Hospitalized and Ventilated Patients Receiving Standard of Care Antibiotics for Bacterial Pneumonia
Author / Creator:Katsube, Takayuki ; Wajima, Toshihiro ; Echols, Roger ; Portsmouth, Simon ; Ariyasu, Mari ; Rodvold, Keith ; Nicolau, David P
Publisher:US: Oxford University Press
Journal title:Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S668-S668
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 14
ArticlesPeer ReviewedFull Text
1266. Characterization of Shifts in Minimum Inhibitory Concentrations During Treatment with Cefiderocol or Comparators in the Phase 3 CREDIBLE-CR and APEKS-NP Studies
Author / Creator:Takemura, Miki ; Yamano, Yoshinori ; Matsunaga, Yuko ; Ariyasu, Mari ; Echols, Roger ; Den Nagata, Tsutae
Publisher:US: Oxford University Press
Journal title:Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S649-S650
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 15
ArticlesPeer ReviewedFull Text
165. Cefiderocol Treatment for Serious Infections Caused by Carbapenem-resistant Bacteria: Post-hoc Analysis of Outcomes by Pathogen in the CREDIBLE-CR Study
Author / Creator:Matsunaga, Yuko ; Ariyasu, Mari ; Takemura, Miki ; Yamano, Yoshinori ; Toyoizumi, Kiichiro ; Kinoshita, Masahiro ; Echols, Roger ; Den Nagata, Tsutae
Publisher:US: Oxford University Press
Journal title:Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S212-S212
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 16
ArticlesPeer ReviewedFull Text
1271. Efficacy and Safety of Cefiderocol and Best Available Therapy in Patients with Serious Infections Caused by Carbapenem-Resistant Gram-Negative Infections: Results of the Pathogen-Focused Phase 3...
Author / Creator:Bassetti, Matteo ; Echols, Roger ; Matsunaga, Yuko ; Portsmouth, Simon ; Ariyasu, Mari ; Toyoizumi, Kiichiro ; Doi, Yohei ; Den Nagata, Tsutae
Publisher:US: Oxford University Press
Journal title:Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S652-S653
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 17
ArticlesPeer ReviewedFull Text
Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens--The International, Multicenter, Randomized, Open-Label, Phase 3 C...
Author / Creator:Bassetti, Matteo ; Ariyasu, Mari ; Binkowitz, Bruce ; Den Nagata, Tsutae ; Echols, Roger M ; Matsunaga, Yuko ; Toyoizumi, Kiichiro ; Doi, Yohei
Publisher:Dove Medical Press Limited
Journal title:Infection and drug resistance, 2019-11, p.3607
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 18
ArticlesPeer ReviewedFull Text
1316. Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol in Critically Ill Patients
Author / Creator:Katsube, Takayuki ; Kawaguchi, Nao ; Matsunaga, Yuko ; Ariyasu, Mari ; Den Nagata, Tsutae ; Portsmouth, Simon ; Paterson, David ; Satlin, Michael J ; Zeitlinger, Markus ; Echols, Roger ; Wajima, Toshihiro
Publisher:US: Oxford University Press
Journal title:Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S669-S670
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 19
ArticlesPeer ReviewedFull Text
LB4. Efficacy and Safety of Cefiderocol vs. High-Dose Meropenem in Patients with Nosocomial Pneumonia—Results of a Phase 3, Randomized, Multicenter, Double-Blind, Non-Inferiority Study
Author / Creator:Wunderink, Richard G ; Matsunaga, Yuko ; Ari, Mari ; Ariyasu, Mari ; Echols, Roger ; Menon, Anju ; Den Nagata, Tsutae
Publisher:Oxford: Oxford University Press
Journal title:Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S994-S994
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 20
ArticlesPeer ReviewedFull Text
666. Efficacy and Safety of Cefiderocol According to Renal Impairment in Patients With Complicated Urinary Tract Infection (cUTI) in a Phase 2 Study
Author / Creator:Portsmouth, Simon ; Echols, Roger ; Machida, Mitsuaki ; Camilo Arjona Ferreira, Juan ; Ariyasu, Mari ; Den Nagata, Tsutae
Publisher:Oxford: Oxford University Press
Journal title:Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S305-S305
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Showing 1 to 20 of 28 results

Export record to excel

Export this record

Export record to excel

Compassionate Use of Cefiderocol as Adjunctive Treatment of Native Aortic Valve Endocarditis Due to Extremely Drug-resistant Pseudomonas aeruginosa

Export this record

Export record to excel

Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings

Export this record

Export record to excel

A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults

Export this record

Export record to excel

Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens – The International, Multicenter, Randomized, Open-Label, Phase 3...

Export this record

Export record to excel

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, mult...

Export this record

Export record to excel

Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial

Export this record

Export record to excel

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

Export this record

Export record to excel

Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study

Export this record

Export record to excel

A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial

Export this record

Export record to excel

Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

Export this record

Export record to excel

Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults

Export this record

Export record to excel

Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Heal...

Export this record

Export record to excel

1311. Intrapulmonary Pharmacokinetics of Cefiderocol in Hospitalized and Ventilated Patients Receiving Standard of Care Antibiotics for Bacterial Pneumonia

Export this record

Export record to excel

1266. Characterization of Shifts in Minimum Inhibitory Concentrations During Treatment with Cefiderocol or Comparators in the Phase 3 CREDIBLE-CR and APEKS-NP Studies

Export this record

Export record to excel

165. Cefiderocol Treatment for Serious Infections Caused by Carbapenem-resistant Bacteria: Post-hoc Analysis of Outcomes by Pathogen in the CREDIBLE-CR Study

Export this record

Export record to excel

1271. Efficacy and Safety of Cefiderocol and Best Available Therapy in Patients with Serious Infections Caused by Carbapenem-Resistant Gram-Negative Infections: Results of the Pathogen-Focused Phase 3...

Export this record

Export record to excel

Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens--The International, Multicenter, Randomized, Open-Label, Phase 3 C...

Export this record

Export record to excel

1316. Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol in Critically Ill Patients

Export this record

Export record to excel

LB4. Efficacy and Safety of Cefiderocol vs. High-Dose Meropenem in Patients with Nosocomial Pneumonia—Results of a Phase 3, Randomized, Multicenter, Double-Blind, Non-Inferiority Study

Export this record

Export record to excel

666. Efficacy and Safety of Cefiderocol According to Renal Impairment in Patients With Complicated Urinary Tract Infection (cUTI) in a Phase 2 Study

Refine your search